China’s Asymchem Said to Guide Listing Price at HK$388_老虎社区_美港股上老虎

China’s Asymchem Said to Guide Listing Price at HK$388

Bloomberg2021-12-03

Shenzhen-listed Asymchem is selling 18.4 million shares Asymchem will raise $917 million in Hong Kong listing Chinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

967

claratan
·2021-12-06
Nice
回复
3
举报
收起
- Ichua:
  Ok
  2021-12-06
  回复
  举报
Slee49
·2021-12-05
Like
回复
2
举报
收起
- Slee49:
  Like
  2021-12-05
  回复
  举报
eaafb7d
·2021-12-05
Wow
回复
1
举报
US_watchlist
·2021-12-05
Please like and comment. Thanks
回复
2
举报
收起
- 迈向财富自由:
  Ok
  2021-12-05
  回复
  举报
TradeMore
·2021-12-05
Ok
回复
2
举报
收起
- OldCitron:
  👌
  2021-12-05
  回复
  举报
Ahsiang
·2021-12-05
Swee
回复
2
举报
SSVC
·2021-12-05
Too expensive
回复
3
举报
OO_898
·2021-12-05
Like
回复
2
举报
Ermmmmmm
·2021-12-05
Need to study more
回复
5
举报
收起
- 48bfd3e1:
  Ok
  2021-12-05
  回复
  举报
YTRT
·2021-12-05
Thanks
回复
3
举报
Simplewind
·2021-12-05
Pls like. Thanks
回复
3
举报
收起
- Decaffed:
  Okok
  2021-12-05
  回复
  举报
zeeling
·2021-12-05
Great
回复
4
举报
SeanSak
·2021-12-05
Like n comment
回复
1
举报
收起
- zeeling:
  Great
  2021-12-05
  回复
  举报
andrew123
·2021-12-05
Think twice esp china stk for now
回复
1
举报
ACCY
·2021-12-04
Good buy? 🤔
回复
2
举报
收起
- matcha_latte:
  hmmm
  2021-12-05
  回复
  举报
SFern
·2021-12-04
Good
回复
1
举报
收起
- SFern:
  Great
  2021-12-04
  回复
  举报
SFern
·2021-12-04
Good
回复
点赞
举报
HuatKueh313
·2021-12-04
Huat
回复
1
举报
收起
- HuatKueh313:
  huat
  2021-12-04
  回复
  举报
scenichu
·2021-12-04
[Smile] [Smile] [Smile]
回复
3
举报
YTRT
·2021-12-04
Thanks
回复
2
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1162832222?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-03 23:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162832222","market":"us","top_or_hot":-1,"title":"China’s Asymchem Said to Guide Listing Price at HK$388","media":"Bloomberg","content":"<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06821","symbol_name":"凯莱英","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","article_id":"1162832222","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","pubTimestamp":1638544942,"columns":[],"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"06821":"凯莱英"},"translate_title":"中国Asymchem宣布指导上市价格为388港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06821":0.9},"content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":608676887,"gmtCreate":1638742195860,"gmtModify":1638742196219,"author":{"id":"3573731928321338","authorId":"3573731928321338","name":"claratan","avatar":"https://static.tigerbbs.com/9c6bbdac9048ff2e4b740f272576e2be","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3573731928321338","authorIdStr":"3573731928321338"},"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608676887","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6864812,"gmtCreate":1638764368397,"gmtModify":1638764368505,"authorId":3554848762875033,"author":{"id":3554848762875033,"idStr":"3554848762875033","authorId":3554848762875033,"name":"Ichua","avatar":"https://static.tigerbbs.com/175ebc8e659de3f491645e9236066d54","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608676887,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":608667724,"gmtCreate":1638717166371,"gmtModify":1638717166663,"author":{"id":"3581993357014262","authorId":"3581993357014262","name":"Slee49","avatar":"https://static.tigerbbs.com/a4a9c556617a3ec3446f5c1c667b4aa0","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3581993357014262","authorIdStr":"3581993357014262"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608667724","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6857176,"gmtCreate":1638717179953,"gmtModify":1638717180040,"authorId":3581993357014262,"author":{"id":3581993357014262,"idStr":"3581993357014262","authorId":3581993357014262,"name":"Slee49","avatar":"https://static.tigerbbs.com/a4a9c556617a3ec3446f5c1c667b4aa0","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608667724,"type":1,"supId":0,"prevId":0,"content":"<u>Like</u>","text":"<u>Like</u>","html":"<u>Like</u>"}],"langContent":"CN"},{"id":608637800,"gmtCreate":1638708113431,"gmtModify":1638708113431,"author":{"id":"4101245912275130","authorId":"4101245912275130","name":"eaafb7d","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4101245912275130","authorIdStr":"4101245912275130"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608637800","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":608841664,"gmtCreate":1638691468367,"gmtModify":1638691468724,"author":{"id":"3581244873474125","authorId":"3581244873474125","name":"US_watchlist","avatar":"https://static.tigerbbs.com/c45e6bbe1cefb0fecde067a20b3c788f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581244873474125","authorIdStr":"3581244873474125"},"htmlText":"Please like and comment. Thanks","listText":"Please like and comment. Thanks","text":"Please like and comment. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608841664","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6856028,"gmtCreate":1638707492780,"gmtModify":1638707492811,"authorId":3581679692120260,"author":{"id":3581679692120260,"idStr":"3581679692120260","authorId":3581679692120260,"name":"迈向财富自由","avatar":"https://static.tigerbbs.com/041a50da1c64743f0c9442a4e6f619d0","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608841664,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":608884346,"gmtCreate":1638681725122,"gmtModify":1638681725223,"author":{"id":"4097720712211120","authorId":"4097720712211120","name":"TradeMore","avatar":"https://static.tigerbbs.com/976c10f5e71e9a3b002205015f764d44","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4097720712211120","authorIdStr":"4097720712211120"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608884346","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6854640,"gmtCreate":1638694639627,"gmtModify":1638694639658,"authorId":3571555251496435,"author":{"id":3571555251496435,"idStr":"3571555251496435","authorId":3571555251496435,"name":"OldCitron","avatar":"https://static.tigerbbs.com/19642cef76c55c41de70d3d33a39db1c","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608884346,"type":1,"supId":0,"prevId":0,"content":"👌","text":"👌","html":"👌"}],"langContent":"CN"},{"id":608893098,"gmtCreate":1638674781681,"gmtModify":1638674781850,"author":{"id":"3582617881962608","authorId":"3582617881962608","name":"Ahsiang","avatar":"https://static.tigerbbs.com/310f96e7696af85ae33ece774a483d15","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3582617881962608","authorIdStr":"3582617881962608"},"htmlText":"Swee","listText":"Swee","text":"Swee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608893098","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":608899579,"gmtCreate":1638674755599,"gmtModify":1638674756597,"author":{"id":"3574906731000207","authorId":"3574906731000207","name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3574906731000207","authorIdStr":"3574906731000207"},"htmlText":"Too expensive&nbsp;","listText":"Too expensive&nbsp;","text":"Too expensive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608899579","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":608803786,"gmtCreate":1638673598357,"gmtModify":1638673598522,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608803786","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":608156962,"gmtCreate":1638669889957,"gmtModify":1638669890190,"author":{"id":"4087557783698070","authorId":"4087557783698070","name":"Ermmmmmm","avatar":"https://static.tigerbbs.com/b89bbeb73fe9212f0b5efc7185ae8a51","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087557783698070","authorIdStr":"4087557783698070"},"htmlText":"Need to study more&nbsp;","listText":"Need to study more&nbsp;","text":"Need to study more","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608156962","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6850782,"gmtCreate":1638670424497,"gmtModify":1638670424590,"authorId":4088591126250580,"author":{"id":4088591126250580,"idStr":"4088591126250580","authorId":4088591126250580,"name":"48bfd3e1","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608156962,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":608124091,"gmtCreate":1638669239416,"gmtModify":1638669239530,"author":{"id":"4088994282428880","authorId":"4088994282428880","name":"YTRT","avatar":"https://static.tigerbbs.com/344b95c303c752be1a1e529b4f91ae17","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4088994282428880","authorIdStr":"4088994282428880"},"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608124091","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":608126236,"gmtCreate":1638669015212,"gmtModify":1638669015390,"author":{"id":"3572867658695568","authorId":"3572867658695568","name":"Simplewind","avatar":"https://static.tigerbbs.com/5cec05c297ad50a1f25f590f1266e874","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3572867658695568","authorIdStr":"3572867658695568"},"htmlText":"Pls like. Thanks","listText":"Pls like. Thanks","text":"Pls like. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608126236","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6850932,"gmtCreate":1638670976468,"gmtModify":1638670976503,"authorId":3579499629384357,"author":{"id":3579499629384357,"idStr":"3579499629384357","authorId":3579499629384357,"name":"Decaffed","avatar":"https://static.tigerbbs.com/233f0ca062b0a4857cce119c33bc9a64","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608126236,"type":1,"supId":0,"prevId":0,"content":"Okok","text":"Okok","html":"Okok"}],"langContent":"CN"},{"id":608186236,"gmtCreate":1638666315842,"gmtModify":1638666316089,"author":{"id":"3578196134540225","authorId":"3578196134540225","name":"zeeling","avatar":"https://static.tigerbbs.com/901d745faf2cd5225a6dbed44ad6236a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578196134540225","authorIdStr":"3578196134540225"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608186236","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":608197715,"gmtCreate":1638661843450,"gmtModify":1638661843677,"author":{"id":"3581585664475701","authorId":"3581585664475701","name":"SeanSak","avatar":"https://static.tigerbbs.com/4a62d3d455150e01d4dc6c67bd4f9c0d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581585664475701","authorIdStr":"3581585664475701"},"htmlText":"Like n comment","listText":"Like n comment","text":"Like n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608197715","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6849484,"gmtCreate":1638666326195,"gmtModify":1638666326298,"authorId":3578196134540225,"author":{"id":3578196134540225,"idStr":"3578196134540225","authorId":3578196134540225,"name":"zeeling","avatar":"https://static.tigerbbs.com/901d745faf2cd5225a6dbed44ad6236a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608197715,"type":1,"supId":0,"prevId":0,"content":"Great","text":"Great","html":"Great"}],"langContent":"CN"},{"id":608191505,"gmtCreate":1638660560166,"gmtModify":1638660560722,"author":{"id":"3576260758860416","authorId":"3576260758860416","name":"andrew123","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3576260758860416","authorIdStr":"3576260758860416"},"htmlText":"Think twice esp china stk for now","listText":"Think twice esp china stk for now","text":"Think twice esp china stk for now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608191505","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":608323013,"gmtCreate":1638630862986,"gmtModify":1638630863285,"author":{"id":"3579758808989513","authorId":"3579758808989513","name":"ACCY","avatar":"https://static.tigerbbs.com/a44626552831eb06aa01cf85dcaf7422","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3579758808989513","authorIdStr":"3579758808989513"},"htmlText":"Good buy? 🤔&nbsp;","listText":"Good buy? 🤔&nbsp;","text":"Good buy? 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608323013","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6847798,"gmtCreate":1638656272688,"gmtModify":1638656272719,"authorId":3581766638376505,"author":{"id":3581766638376505,"idStr":"3581766638376505","authorId":3581766638376505,"name":"matcha_latte","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608323013,"type":1,"supId":0,"prevId":0,"content":"<u>hmmm</u>","text":"<u>hmmm</u>","html":"<u>hmmm</u>"}],"langContent":"CN"},{"id":608362731,"gmtCreate":1638630076118,"gmtModify":1638630076118,"author":{"id":"3582938826092533","authorId":"3582938826092533","name":"SFern","avatar":"https://static.tigerbbs.com/81a61c88544234a53cc63054a8f769b1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582938826092533","authorIdStr":"3582938826092533"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608362731","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6846298,"gmtCreate":1638630083798,"gmtModify":1638630083884,"authorId":3582938826092533,"author":{"id":3582938826092533,"idStr":"3582938826092533","authorId":3582938826092533,"name":"SFern","avatar":"https://static.tigerbbs.com/81a61c88544234a53cc63054a8f769b1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608362731,"type":1,"supId":0,"prevId":0,"content":"Great","text":"Great","html":"Great"}],"langContent":"CN"},{"id":608362220,"gmtCreate":1638630064502,"gmtModify":1638630064612,"author":{"id":"3582938826092533","authorId":"3582938826092533","name":"SFern","avatar":"https://static.tigerbbs.com/81a61c88544234a53cc63054a8f769b1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582938826092533","authorIdStr":"3582938826092533"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608362220","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":608368671,"gmtCreate":1638629573507,"gmtModify":1638629573603,"author":{"id":"3565832091209909","authorId":"3565832091209909","name":"HuatKueh313","avatar":"https://static.tigerbbs.com/31fbe827eb784eecc8d7e3bf6018cb01","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3565832091209909","authorIdStr":"3565832091209909"},"htmlText":"Huat","listText":"Huat","text":"Huat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608368671","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6846235,"gmtCreate":1638629579593,"gmtModify":1638629579621,"authorId":3565832091209909,"author":{"id":3565832091209909,"idStr":"3565832091209909","authorId":3565832091209909,"name":"HuatKueh313","avatar":"https://static.tigerbbs.com/31fbe827eb784eecc8d7e3bf6018cb01","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":608368671,"type":1,"supId":0,"prevId":0,"content":"<u>huat</u>","text":"<u>huat</u>","html":"<u>huat</u>"}],"langContent":"CN"},{"id":608393482,"gmtCreate":1638616040750,"gmtModify":1638616041049,"author":{"id":"3554951292305587","authorId":"3554951292305587","name":"scenichu","avatar":"https://static.tigerbbs.com/e2d5eb7de52de2d76f08c9564d26fe90","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3554951292305587","authorIdStr":"3554951292305587"},"htmlText":"[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;","text":"[Smile] [Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608393482","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":608079035,"gmtCreate":1638586940830,"gmtModify":1638586940940,"author":{"id":"4088994282428880","authorId":"4088994282428880","name":"YTRT","avatar":"https://static.tigerbbs.com/344b95c303c752be1a1e529b4f91ae17","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4088994282428880","authorIdStr":"4088994282428880"},"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608079035","repostId":1162832222,"repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":967,"commentSize":55,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}